Cerebrovascular reactivity in Alzheimer's disease signature regions is associated with mild cognitive impairment in adults with hypertension

Author:

Aslanyan Vahan1ORCID,Mack Wendy J.1,Ortega Nancy E.2,Nasrallah Ilya M.3,Pajewski Nicholas M.4,Williamson Jeff D.5,Pa Judy2ORCID

Affiliation:

1. Department of Population and Public Health Sciences Keck School of Medicine University of Southern California Los Angeles California USA

2. Alzheimer's Disease Cooperative Study (ADCS) Department of Neurosciences University of California, San Diego La Jolla California USA

3. Department of Radiology University of Pennsylvania Philadelphia Pennsylvania USA

4. Department of Biostatistics and Data Science Division of Public Health Science Wake Forest University School of Medicine Winston‐Salem North Carolina USA

5. Section of Gerontology and Geriatric Medicine Department of Internal Medicine Wake Forest University School of Medicine Winston‐Salem North Carolina USA

Abstract

AbstractINTRODUCTIONVascular risk factors contribute to cognitive decline suggesting that maintaining cerebrovascular health could reduce dementia risk. The objective of this study is to evaluate the association of cerebrovascular reactivity (CVR), a measure of brain blood vessel elasticity, with mild cognitive impairment (MCI) and dementia.METHODSParticipants were enrolled in the Systolic Blood Pressure Intervention Trial Memory and Cognition in Decreased Hypertension (SPRINT‐MIND) magnetic resonance imaging substudy. Baseline CVR in Alzheimer's disease (AD) signature regions were primary variables of interest. The occipital pole and postcentral gyrus were included as control regions.RESULTSHigher AD composite CVR was associated with lower MCI risk. No significant associations between inferior temporal gyrus, occipital pole, or postcentral gyrus CVR and MCI risk, or any regional CVR–combined risk associations were observed.DISCUSSIONCVR in AD signature regions is negatively associated with occurrence of MCI, implicating CVR in AD signature regions as a potential mechanism leading to cognitive impairment.

Funder

National Institutes of Health

Takeda Pharmaceuticals International

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3